Confirmed Speakers and Tentative Speech Titles

Paraskevi (Evi) Giannakakou, Professor, Cornell University, USA

Microtubule-regulated pathways: Novel opportunities for targeted anticancer therapies

Alexander D?mling, Professor, University of Groningen, Netherlands

Novel Tubulysin Synthesis based on convergent multicomponent reaction

Jack A. Tuszynski, Professor, University of Alberta, Canada

Computational design of isotype- and mutant-specific tubular binding agents: examples of colchicine, laulimalide and peloruside derivatives

Karl-Heinz Altmann, Professor, ETH Zurich, Switzerland

Adventures with Tubulin-Interacting Natural Products: From Chemistry to Biology and Complex Structures

Susan L. Mooberry, Professor, UT Health San Antonio, USA

Microtubule targeting drugs rapidly and differentially inhibit oncogenic signaling and this likely contributes to their clinical efficacies

Fernando Díaz, Senior Staff Scientist, CIB, CSIC, Spain

Tubulin activity modulation by small molecules. A historical overview

Carlos Galmarini, PharmMar S.A., Spain

Marine-derived tubulin-binding agents as payloads for antibody-drug conjugates

Antonina Roll-Mecak, Investigator, NINDS, NIH, USA

Microtubule cryptography: the effects of tubulin diversity on polymer structure and dynamics

Carlo Ballatore, Associate Professor, UC San Diego, USA

Microtubule Stabilizing Agents as Possible Treatments for Alzheimer’s Disease and Related Tauopathies

Richard E. Taylor, Professor, University of Notre Dame, USA

Synthesis, Biosynthesis and Conformation-Activity Relationships of the Marine Polyketide, Zampanolide

Andrea Prota, Investigator, PSI, Switzerland

Microtubule-targeting agents: Strategies to hijack the cytoskeleton

Susan Bane, Professor, SUNY Binghamton, USA

Chemistry on and around microtubules